FBXO45 and non-small cell lung carcinoma: In this work, we reported that Fbxo45 is overexpressed in NSCLC and is closely related to the overall survival of NSCLC patients and the capability to promote tumor cell growth in vitro and in vivo (Figs 1 and 2).